Efficacy and safety of lapatinib and trastuzumab for HER2-positive breast cancer: a systematic review and meta-analysis of randomised controlled trials.

BMJ Open · 2017 · PMC5353336 · PMID 28289045

Europe PMC DOI

hedged sentence

0.0480

closest p · 1.0× alpha

0.0480

boldest claim

The sentences

did not reach statistical significancep=0.048actually significant

40 However, the difference did not reach statistical significance (p=0.048).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.